Jonathan E. Alpert, MD, PhD

Jonathan Edward Alpert, MD, PhD, is Dorothy and Marty Silverman Chair, Psychiatry and Behavioral Sciences at Montefiore Einstein and Professor, Psychiatry, Neuroscience and Pediatrics at our Albert Einstein College of Medicine. Dr. Alpert’s clinical focus centers on the evaluation and treatment of complex mood and anxiety disorders.

After obtaining his Bachelor of Arts at Yale College in 1977, Dr. Alpert earned his Doctor of Medicine at Yale University in 1986. He earned his Doctor of Philosophy in behavioral pharmacology at the University of Cambridge in Cambridge, England, in 1987 on a Marshall Scholarship. Dr. Alpert completed residency training in pediatrics at the Boston Children's Hospital in 1989. He then completed his psychiatry residency at McLean Hospital in 1992, where he was Chief Resident in psychopharmacology in his final year. He then held faculty and leadership roles at the Massachusetts General Hospital and Harvard Medical School through 2017.

Dr. Alpert’s research focuses on the treatment and biomarkers related to major depressive disorder and bipolar disorder. He has been principal investigator and co-investigator on numerous funded research projects and his work has been published in many peer-reviewed publications. Dr. Alpert serves on the editorial board of several psychiatry journals and has over 240 publications. He has also given many national and international invited presentations.

Dr. Alpert is a member of the American Psychiatric Association (APA), the American Society of Clinical Psychopharmacology, the American College of Psychiatrists, the Association of Chairs of Departments of Psychiatry, the Society of Biological Psychiatry and the Anxiety and Depression Association, among others. He chairs the Council on Research of the APA. Dr. Alpert has received teaching, mentorship and service awards from the Massachusetts General Hospital, Partners HealthCare, Harvard Medical School, the Depression Bipolar Support Alliance, the Association for Behavioral and Cognitive Therapies and the American Psychiatric Association.